User profiles for Srinivas Shenoy

Srinivas Vinayak Shenoy

Associate Professor , Department of Nephrology , KMC Manipal , MAHE , Manipal
Verified email at manipal.edu
Cited by 134

Sodium‐glucose cotransporter‐2 inhibitors and non‐steroidal mineralocorticoid receptor antagonists: Ushering in a new era of nephroprotection beyond renin …

SV Shenoy, SP Nagaraju, MV Bhojaraja… - …, 2021 - Wiley Online Library
The therapeutic options for preventing or slowing the progression of chronic kidney disease
(CKD) have been thus far limited. While angiotensin converting enzyme inhibitors (ACEi) …

[HTML][HTML] 2-deoxy-d-glucose as an adjunct to standard of care in the medical management of COVID-19: a proof-of-concept and dose-ranging randomised phase II …

AN Bhatt, S Shenoy, S Munjal, V Chinnadurai… - BMC Infectious …, 2022 - Springer
Background At present, no single efficacious therapeutic exists for acute COVID-19
management and a multimodal approach may be necessary. 2-deoxy-d-glucose (2-DG) is a …

Chronic kidney disease of unknown aetiology: A comprehensive review of a global public health problem

…, A Bangera, SP Nagaraju, SV Shenoy… - Tropical Medicine & …, 2023 - Wiley Online Library
The term chronic kidney disease of unknown aetiology (CKDu) refers to chronic kidney
disease (CKD) in the absence of diabetes, long‐standing hypertension, glomerulonephritis, …

[HTML][HTML] Pharmacokinetics of DFN-15, a novel oral solution of celecoxib, versus celecoxib 400-mg capsules: a randomized crossover study in fasting healthy …

A Pal, S Shenoy, A Gautam, S Munjal, J Niu… - Clinical Drug …, 2017 - Springer
Background COX-2 inhibitors can be effective for acute migraine, but none is supplied in a
rapidly absorbed, ready-to-use oral liquid formulation. DFN-15, a novel oral liquid formulation …

[HTML][HTML] Novel biomarkers for prognosticating diabetic kidney disease progression

SM Swaminathan, IR Rao, SV Shenoy… - … Urology and Nephrology, 2023 - Springer
The global burden of diabetic kidney disease (DKD) is escalating, and it remains as a
predominant cause of the end-stage renal disease (ESRD). DKD is associated with increased …

Measurement of blood pressure in chronic kidney disease: time to change our clinical practice-a comprehensive review

SP Nagaraju, SV Shenoy, IR Rao… - … of Nephrology and …, 2022 - Taylor & Francis
Chronic kidney disease (CKD) is extremely common all over the world and is strongly linked
to cardiovascular disease (CVD). The great majority of CKD patients have hypertension, …

An evaluation of the changes in the plasma levels of cytokines in rheumatoid arthritis patients on methotrexate therapy

S Shenoy - 2006 - search.proquest.com
Srinivas Shenoy B. in partial fulfilment of the requirement for the degree of Doctor of …
Srinivas Shenoy B. in partial fulfilment of the requirement for the degree of Doctor of Medicine …

2-Deoxy-D-glucose as an adjunct to standard of care in the medical management of COVID-19: a proof-of-concept & dose-ranging randomised clinical trial

AN Bhatt, S Shenoy, S Munjal, V Chinnadurai… - medRxiv, 2021 - medrxiv.org
… Drs Srinivas Shenoy, Sagar Munjal and A Shanavas: The authors are paid employees of Dr
Reddy’s Laboratories Limited. None of the authors received any separate compensation for …

[HTML][HTML] Minocycline extended-release comparison with doxycycline for the treatment of rosacea: a randomized, head-to-head, clinical trial

…, S Alikunju, A Gautam, S Shenoy… - The Journal of …, 2021 - ncbi.nlm.nih.gov
Objective Minocycline efficacy for the treatment of papulopustular rosacea (PPR) has not been
evaluated in clinical trials at levels demonstrated to stay below the antimicrobial threshold…

Acute kidney injury in patients with cirrhosis of liver: Clinical profile and predictors of outcome

S Shetty, SP Nagaraju, S Shenoy, RP Attur… - Indian journal of …, 2018 - Springer
Background Acute kidney injury (AKI) is a common complication of liver cirrhosis and is
associated with poor survival. We studied the clinical profile and predictors of in-hospital …